J.P. Morgan Maintains ESRX Overweight Rating

J.P. Morgan has reiterated Express Scripts' ESRX Overweight Rating. According to J.P. Morgan, “We reiterate our OW rating on ESRX. Shares trade at 17.0x our FY11 adjusted EPS estimate of $3.20, representing a discount to the company's historical valuation and our projected EPS growth rate over the next two years.” ESRX has a $69.00 Price Target and closed yesterday at $53.50 a share.